|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.73 HKD | -2.67% |
|
-2.67% | -18.89% |
| Apr. 01 | PuraPharm's Net Loss Shrinks in 2023; Revenue Falls 9% | MT |
| Mar. 28 | PuraPharm Corporation Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
PuraPharm Corporation Limited reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was HKD 406.86 million compared to HKD 448.07 million a year ago. Net loss was HKD 106.08 million compared to HKD 120.21 million a year ago.
Basic loss per share from continuing operations was HKD 0.2685 compared to HKD 0.3047 a year ago. Diluted loss per share from continuing operations was HKD 0.2685 compared to HKD 0.3047 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -18.89% | 37.85M | |
| +37.08% | 5.92B | |
| -17.43% | 4.51B | |
| -9.46% | 3.15B | |
| +0.51% | 3.1B | |
| -3.53% | 2.42B | |
| +41.15% | 1.97B | |
| -5.15% | 1.68B | |
| +0.09% | 1.65B | |
| -10.38% | 1.53B |
PURAPHARM CORPORATION LIMITED 
